Ajou University repository

Biomaterials
ISSN
  • E1878-5905
  • P0142-9612
Publisher

Elsevier Science Inc.

Listed on
(Coverage)

JCR1997-2023

SJR1999-2020;2022-2023

CiteScore2011-2023

SCI2010-2019

SCIE2010-2024

CC2016-2024

SCOPUS2017-2024

MEDLINE2016-2024

EMBASE2016-2024

Active
Active

based on the information

  • SCOPUS:2024-10
Country
NETHERLANDS
Aime & Scopes
Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.
Article List

Showing results 1 to 7 of 7

One-shot dual gene editing for drug-resistant pancreatic cancer therapy
  • Won, Eun Jeong;
  • Park, Hyeji;
  • Chang, Seung Hee;
  • Kim, Jin Hyun;
  • Kwon, Hojeong;
  • Cho, Young Seok;
  • Yoon, Tae Jong
  • 2021-12-01
  • Biomaterials, Vol.279
  • Elsevier Ltd
Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment
  • Kang, Li Jung;
  • Yoon, Juhwan;
  • Rho, Jun Gi;
  • Han, Hwa Seung;
  • Lee, Seulbi;
  • Oh, Young Soo;
  • Kim, Hwan;
  • Kim, Eunha;
  • Kim, Seok Jung;
  • Lim, Yong Taik;
et al
  • 2021-08-01
  • Biomaterials, Vol.275
  • Elsevier Ltd
NIR fluorescence for monitoring in vivo scaffold degradation along with stem cell tracking in bone tissue engineeringoa mark
  • Kim, Soon Hee;
  • Park, Ji Hoon;
  • Kwon, Jin Seon;
  • Cho, Jae Gu;
  • Park, Kate G.;
  • Park, Chan Hum;
  • Yoo, James J.;
  • Atala, Anthony;
  • Choi, Hak Soo;
  • Kim, Moon Suk;
et al
  • 2020-11-01
  • Biomaterials, Vol.258
  • Elsevier Ltd
The αC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseasesoa mark
  • Shah, Masaud;
  • Kim, Gi Young;
  • Achek, Asma;
  • Cho, Eun Young;
  • Baek, Wook Young;
  • Choi, Yang Seon;
  • Lee, Wang Hee;
  • Kim, Dong Jin;
  • Lee, Sang Ho;
  • Kim, Wook;
et al
  • 2020-07-01
  • Biomaterials, Vol.245
  • Elsevier Ltd
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
  • 2020-02-01
  • Biomaterials, Vol.232
  • Elsevier Ltd
Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice
  • Mun, Chin Hee;
  • Kim, Jin Ock;
  • Ahn, Sung Soo;
  • Yoon, Taejun;
  • Kim, Su Jeong;
  • Ko, Eunhee;
  • Noh, Hee Dong;
  • Park, Yong Beom;
  • Jung, Hak Jun;
  • Kim, Tae Sung;
et al
  • 2019-11-01
  • Biomaterials, Vol.220
  • Elsevier Ltd
An injectable, electrostatically interacting drug depot for the treatment of rheumatoid arthritis
  • 2018-02-01
  • Biomaterials, Vol.154, pp.86-98
  • Elsevier Ltd
1